Search
for
Sort by
Research 30 of 289
- Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Clomipramine suppresses ACE2-mediated SARS-CoV-2 entry
- Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
- Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Redefining hormone resistance in prostate cancer
- Is COVID-19 Gender-sensitive?
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility